A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease
NCT ID: NCT01036048
Last Updated: 2009-12-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5806 participants
OBSERVATIONAL
2009-05-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Drug Eluting Stent Zilver PTX vs Bare Metal Stent Zilver Flex
NCT05296031
Retrospective Analysis of Balloon Expandable Covered Stenting in the Common Femoral Artery
NCT05220540
Edwards Lifesciences Self-Expanding Stent Peripheral Vascular Disease Study
NCT00673985
The eSVS® Mesh Randomized Post-Market Study
NCT01462721
Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis
NCT02568293
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cabg disease
pts with saphenous vein graft disease
drug eluting stent
pts with cabg disease treated with drug eluting stent
bare metal stent
pts with cabg disease treated with bare metal stent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
drug eluting stent
pts with cabg disease treated with drug eluting stent
bare metal stent
pts with cabg disease treated with bare metal stent
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* randomized studies
* not randomized studies
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catholic University of the Sacred Heart
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Catholic University of the Sacred Heart
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ALESSANDRO LUPI, MD
Role: PRINCIPAL_INVESTIGATOR
OSPEDALE MAGGIORE NOVARA
ELIANO NAVARESE, MD
Role: PRINCIPAL_INVESTIGATOR
CATHOLIC UNIVERSITY OF SACRED HEART
References
Explore related publications, articles, or registry entries linked to this study.
Lupi A, Navarese EP, Lazzero M, Sansa M, De Servi S, Serra A, Bongo AS, Buffon A. Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients. Circ J. 2011;75(2):280-9. doi: 10.1253/circj.cj-10-0186. Epub 2010 Dec 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N28LBCF80-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.